HUN

HUN
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.46B ▲ | $198M ▼ | $-25M ▲ | -1.712% ▲ | $-0.14 ▲ | $86M ▲ |
| Q2-2025 | $1.458B ▲ | $302M ▲ | $-158M ▼ | -10.837% ▼ | $-0.92 ▼ | $-46M ▼ |
| Q1-2025 | $1.41B ▼ | $159M ▼ | $-5M ▲ | -0.355% ▲ | $-0.03 ▲ | $115M ▲ |
| Q4-2024 | $1.452B ▼ | $251M ▲ | $-141M ▼ | -9.711% ▼ | $-0.82 ▼ | $13M ▼ |
| Q3-2024 | $1.54B | $192M | $-33M | -2.143% | $-0.12 | $125M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $468M ▲ | $7.082B ▼ | $4.081B ▼ | $2.766B ▼ |
| Q2-2025 | $399M ▲ | $7.147B ▼ | $4.086B ▲ | $2.828B ▼ |
| Q1-2025 | $334M ▼ | $7.232B ▲ | $4.061B ▲ | $2.951B ▼ |
| Q4-2024 | $340M ▲ | $7.114B ▼ | $3.951B ▼ | $2.959B ▼ |
| Q3-2024 | $330M | $7.334B | $3.989B | $3.112B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-25M ▲ | $196M ▲ | $-42M ▼ | $-83M ▼ | $69M ▲ | $153M ▲ |
| Q2-2025 | $-159M ▼ | $91M ▲ | $-38M ▼ | $9M ▼ | $65M ▲ | $54M ▲ |
| Q1-2025 | $12M ▲ | $-74M ▼ | $6M ▲ | $60M ▲ | $-6M ▼ | $-110M ▼ |
| Q4-2024 | $-110M ▼ | $153M ▲ | $-39M ▼ | $-95M ▲ | $10M ▲ | $102M ▲ |
| Q3-2024 | $-21M | $129M | $-7M | $-129M | $-5M | $88M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Diversified | $1.21Bn ▲ | $1.17Bn ▼ | $1.20Bn ▲ | $1.20Bn ▲ |
Product and Service Other | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Specialty | $240.00M ▲ | $240.00M ▲ | $250.00M ▲ | $250.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Huntsman today looks like a specialty chemicals company in the middle of a cyclical downturn but with a more differentiated portfolio than in the past. Earnings and margins have compressed significantly from earlier highs, and the balance sheet, while still anchored by meaningful equity, now has less liquidity and more reliance on future profit recovery. Cash flows remain positive but thinner, underscoring the importance of better operating conditions. On the strategic side, the shift toward specialty chemistries, strong positions in key product areas, and a sustained push in innovation for sectors like insulation, semiconductors, electric vehicles, and advanced materials create real opportunities. The main tension for observers is whether and how quickly cyclical demand and pricing will recover to let these strategic strengths show through in stronger and more stable financial results.
NEWS
November 6, 2025 · 4:30 PM UTC
Huntsman Announces Fourth Quarter 2025 Common Dividend
Read more
November 6, 2025 · 4:18 PM UTC
Huntsman Announces Third Quarter 2025 Earnings
Read more
October 3, 2025 · 4:05 PM UTC
Huntsman to Discuss Third Quarter 2025 Results on November 7, 2025
Read more
September 26, 2025 · 5:30 PM UTC
Huntsman Announces Executive Officer Changes
Read more
September 22, 2025 · 7:20 PM UTC
Huntsman Exploration Announces Effective Date of Name Change to Lux Metals Corp.
Read more
About Huntsman Corporation
https://www.huntsman.comHuntsman Corporation manufactures and sells differentiated organic chemical products worldwide. The company operates through four segments: Polyurethanes, Performance Products, Advanced Materials, and Textile Effects.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.46B ▲ | $198M ▼ | $-25M ▲ | -1.712% ▲ | $-0.14 ▲ | $86M ▲ |
| Q2-2025 | $1.458B ▲ | $302M ▲ | $-158M ▼ | -10.837% ▼ | $-0.92 ▼ | $-46M ▼ |
| Q1-2025 | $1.41B ▼ | $159M ▼ | $-5M ▲ | -0.355% ▲ | $-0.03 ▲ | $115M ▲ |
| Q4-2024 | $1.452B ▼ | $251M ▲ | $-141M ▼ | -9.711% ▼ | $-0.82 ▼ | $13M ▼ |
| Q3-2024 | $1.54B | $192M | $-33M | -2.143% | $-0.12 | $125M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $468M ▲ | $7.082B ▼ | $4.081B ▼ | $2.766B ▼ |
| Q2-2025 | $399M ▲ | $7.147B ▼ | $4.086B ▲ | $2.828B ▼ |
| Q1-2025 | $334M ▼ | $7.232B ▲ | $4.061B ▲ | $2.951B ▼ |
| Q4-2024 | $340M ▲ | $7.114B ▼ | $3.951B ▼ | $2.959B ▼ |
| Q3-2024 | $330M | $7.334B | $3.989B | $3.112B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-25M ▲ | $196M ▲ | $-42M ▼ | $-83M ▼ | $69M ▲ | $153M ▲ |
| Q2-2025 | $-159M ▼ | $91M ▲ | $-38M ▼ | $9M ▼ | $65M ▲ | $54M ▲ |
| Q1-2025 | $12M ▲ | $-74M ▼ | $6M ▲ | $60M ▲ | $-6M ▼ | $-110M ▼ |
| Q4-2024 | $-110M ▼ | $153M ▲ | $-39M ▼ | $-95M ▲ | $10M ▲ | $102M ▲ |
| Q3-2024 | $-21M | $129M | $-7M | $-129M | $-5M | $88M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Diversified | $1.21Bn ▲ | $1.17Bn ▼ | $1.20Bn ▲ | $1.20Bn ▲ |
Product and Service Other | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Specialty | $240.00M ▲ | $240.00M ▲ | $250.00M ▲ | $250.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Huntsman today looks like a specialty chemicals company in the middle of a cyclical downturn but with a more differentiated portfolio than in the past. Earnings and margins have compressed significantly from earlier highs, and the balance sheet, while still anchored by meaningful equity, now has less liquidity and more reliance on future profit recovery. Cash flows remain positive but thinner, underscoring the importance of better operating conditions. On the strategic side, the shift toward specialty chemistries, strong positions in key product areas, and a sustained push in innovation for sectors like insulation, semiconductors, electric vehicles, and advanced materials create real opportunities. The main tension for observers is whether and how quickly cyclical demand and pricing will recover to let these strategic strengths show through in stronger and more stable financial results.
NEWS
November 6, 2025 · 4:30 PM UTC
Huntsman Announces Fourth Quarter 2025 Common Dividend
Read more
November 6, 2025 · 4:18 PM UTC
Huntsman Announces Third Quarter 2025 Earnings
Read more
October 3, 2025 · 4:05 PM UTC
Huntsman to Discuss Third Quarter 2025 Results on November 7, 2025
Read more
September 26, 2025 · 5:30 PM UTC
Huntsman Announces Executive Officer Changes
Read more
September 22, 2025 · 7:20 PM UTC
Huntsman Exploration Announces Effective Date of Name Change to Lux Metals Corp.
Read more

CEO
Peter R. Huntsman
Compensation Summary
(Year 2024)

CEO
Peter R. Huntsman
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-07-04 | Forward | 10:1 |
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades

Jefferies
Buy

JP Morgan
Overweight

Wells Fargo
Equal Weight

Morgan Stanley
Equal Weight

RBC Capital
Sector Perform

UBS
Neutral

Citigroup
Neutral

B of A Securities
Underperform

Mizuho
Underperform

Goldman Sachs
Sell
Grade Summary
Price Target
Institutional Ownership

BLACKROCK, INC.
18.377M Shares
$191.492M

VANGUARD GROUP INC
16.357M Shares
$170.443M

BLACKROCK INC.
14.256M Shares
$148.546M

AQR CAPITAL MANAGEMENT LLC
12.063M Shares
$125.696M

APPALOOSA MANAGEMENT LP
8.038M Shares
$83.755M

DIMENSIONAL FUND ADVISORS LP
7.917M Shares
$82.493M

UBS GROUP AG
7.364M Shares
$76.735M

INVESCO LTD.
6.663M Shares
$69.431M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
6.633M Shares
$69.113M

BLACKROCK FUND ADVISORS
5.998M Shares
$62.5M

PZENA INVESTMENT MANAGEMENT LLC
5.394M Shares
$56.204M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
5.131M Shares
$53.467M

MORGAN STANLEY
4.499M Shares
$46.876M

JACOBS LEVY EQUITY MANAGEMENT, INC
3.78M Shares
$39.384M

GEODE CAPITAL MANAGEMENT, LLC
3.347M Shares
$34.875M

MILLENNIUM MANAGEMENT LLC
3.345M Shares
$34.86M

STATE STREET CORP
3.283M Shares
$34.206M

TWO SIGMA INVESTMENTS, LP
2.842M Shares
$29.609M

DEPRINCE RACE & ZOLLO INC
2.335M Shares
$24.334M

SG AMERICAS SECURITIES, LLC
2.086M Shares
$21.738M
Summary
Only Showing The Top 20

